DURAFLEX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 02 Sept 2025)
What this means for you
Registered since 03 Sept 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87058243
- Registration number
- 5851913
- Mark type
- Stylized text
- Filed
- 02 Jun 2016
- Published for opposition
- 01 Nov 2016
- Registered
- 03 Sept 2019
- Attorney of record
- Eva Tan
Goods and services
- Class 005 — Pharmaceuticals: Natural biomaterials for dural regeneration; biological tissue grafts for use in neurosurgery
Owner
- Integra LifeSciences Corporation, Princeton, NJ, US
- Integra LifeSciences Corporation, Plainsboro, NJ, US
- Integra LifeSciences Corporation, Plainsboro, NJ, US
Prosecution history
- 02 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Sept 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Apr 2025 — TEAS SECTION 8 & 15 RECEIVED
- 03 Sept 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 May 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 May 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 May 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 May 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Sept 2019 — REGISTERED-PRINCIPAL REGISTER
- 01 Aug 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Jul 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Jul 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jul 2019 — USE AMENDMENT FILED